Renaissance Technologies’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3M Sell
3,447,460
-118,965
-3% -$562K 0.02% 804
2025
Q1
$16.4M Sell
3,566,425
-287,374
-7% -$1.32M 0.02% 748
2024
Q4
$18.5M Sell
3,853,799
-157,723
-4% -$755K 0.03% 708
2024
Q3
$18.8M Sell
4,011,522
-102,603
-2% -$481K 0.03% 701
2024
Q2
$23.2M Sell
4,114,125
-161,500
-4% -$912K 0.04% 536
2024
Q1
$17.6M Buy
4,275,625
+594,500
+16% +$2.44M 0.03% 695
2023
Q4
$15.5M Buy
3,681,125
+415,100
+13% +$1.75M 0.02% 729
2023
Q3
$14.1M Buy
3,266,025
+153,958
+5% +$665K 0.02% 732
2023
Q2
$20.5M Buy
3,112,067
+176,842
+6% +$1.17M 0.03% 663
2023
Q1
$19.9M Buy
2,935,225
+45,800
+2% +$311K 0.03% 717
2022
Q4
$21.4M Sell
2,889,425
-405,808
-12% -$3M 0.03% 678
2022
Q3
$32.6M Sell
3,295,233
-341,200
-9% -$3.37M 0.05% 457
2022
Q2
$39.6M Buy
3,636,433
+427,819
+13% +$4.66M 0.05% 434
2022
Q1
$36.3M Sell
3,208,614
-3,600
-0.1% -$40.7K 0.04% 454
2021
Q4
$50.4M Sell
3,212,214
-70,108
-2% -$1.1M 0.06% 336
2021
Q3
$56.3M Sell
3,282,322
-28,600
-0.9% -$490K 0.07% 284
2021
Q2
$71.2M Sell
3,310,922
-375,558
-10% -$8.08M 0.09% 233
2021
Q1
$55.4M Sell
3,686,480
-303,923
-8% -$4.56M 0.07% 313
2020
Q4
$52.4M Sell
3,990,403
-390,519
-9% -$5.13M 0.06% 331
2020
Q3
$42.3M Buy
4,380,922
+151,100
+4% +$1.46M 0.04% 434
2020
Q2
$48.4M Buy
4,229,822
+380,168
+10% +$4.35M 0.04% 439
2020
Q1
$39.9M Buy
3,849,654
+396,542
+11% +$4.11M 0.04% 458
2019
Q4
$56.7M Buy
3,453,112
+244,772
+8% +$4.02M 0.04% 476
2019
Q3
$42.6M Buy
3,208,340
+410,290
+15% +$5.45M 0.04% 564
2019
Q2
$39.4M Buy
2,798,050
+233,300
+9% +$3.29M 0.03% 591
2019
Q1
$47.2M Buy
2,564,750
+53,400
+2% +$983K 0.04% 539
2018
Q4
$65.6M Buy
2,511,350
+462,700
+23% +$12.1M 0.07% 314
2018
Q3
$47M Buy
2,048,650
+367,400
+22% +$8.43M 0.05% 467
2018
Q2
$32M Buy
1,681,250
+41,200
+3% +$785K 0.03% 647
2018
Q1
$27.6M Buy
1,640,050
+205,200
+14% +$3.46M 0.03% 752
2017
Q4
$21.8M Buy
1,434,850
+216,600
+18% +$3.29M 0.02% 886
2017
Q3
$21.8M Buy
1,218,250
+120,300
+11% +$2.15M 0.03% 841
2017
Q2
$17.9M Buy
1,097,950
+158,700
+17% +$2.59M 0.02% 918
2017
Q1
$13.2M Buy
939,250
+370,900
+65% +$5.19M 0.02% 1061
2016
Q4
$9.07M Buy
568,350
+136,300
+32% +$2.17M 0.01% 1295
2016
Q3
$7.19M Buy
432,050
+281,000
+186% +$4.68M 0.01% 1381
2016
Q2
$1.69M Sell
151,050
-265,850
-64% -$2.97M ﹤0.01% 2300
2016
Q1
$3.49M Buy
416,900
+79,510
+24% +$665K 0.01% 1881
2015
Q4
$3.14M Buy
+337,390
New +$3.14M 0.01% 1808
2015
Q2
Sell
-195,100
Closed -$1.81M 3400
2015
Q1
$1.81M Buy
+195,100
New +$1.81M ﹤0.01% 1985
2013
Q4
Sell
-256,600
Closed -$2.81M 3041
2013
Q3
$2.81M Sell
256,600
-97,529
-28% -$1.07M 0.01% 1495
2013
Q2
$2.86M Buy
+354,129
New +$2.86M 0.01% 1390